Birdwatch Note
2023-03-10 19:41:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
75%-88% of the ad money pharma spends is on media advertisements. Pharma does not account for 75% of total media advertisements. For the first six months of 2022, the pharma industry spent $5.5 billion on ads. Media ad revenue in the U.S. is $343.45 billion https://www.statista.com/statistics/953104/pharma-industry-tv-ad-spend-us/#:~:text=In%202020%2C%20the%20pharmaceutical%20industry,of%20the%20total%20ad%20spend. https://www.statista.com/topics/5052/television-advertising-in-the-us/#topicHeader__wrapper https://www.fiercepharma.com/marketing/pharma-ad-spending-just-1-year-slow-move-away-tv-and-digital-continues
Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1634221277593444354
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1634278305628147716
- noteId - 1634278305628147716
- participantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
- noteAuthorParticipantId -
- createdAtMillis - 1678477286141
- tweetId - 1634221277593444354
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 75%-88% of the ad money pharma spends is on media advertisements. Pharma does not account for 75% of total media advertisements. For the first six months of 2022, the pharma industry spent $5.5 billion on ads. Media ad revenue in the U.S. is $343.45 billion https://www.statista.com/statistics/953104/pharma-industry-tv-ad-spend-us/#:~:text=In%202020%2C%20the%20pharmaceutical%20industry,of%20the%20total%20ad%20spend. https://www.statista.com/topics/5052/television-advertising-in-the-us/#topicHeader__wrapper https://www.fiercepharma.com/marketing/pharma-ad-spending-just-1-year-slow-move-away-tv-and-digital-continues
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-10 19:41:26 UTC (1678477286141) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-11 02:40:40 UTC (1678502440177) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-11 08:04:02 -0600 | 058E84A582C629DF8EB4118742F173C84E9D695799F32C237ECB93594D44473B | Rating Details |
| 2023-03-11 02:11:26 -0600 | 0BD4990BF3255997269B09B79D8F410C961E941E8728A047A9F5A3FF779F297B | Rating Details |
| 2023-03-11 09:57:37 -0600 | 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 | Rating Details |
| 2023-03-10 14:28:09 -0600 | 22B8D2538D186C242D2CF140AF40F512A2E60EDC20064EF6CAB369B27CFA60F9 | Rating Details |
| 2023-03-11 07:27:38 -0600 | 32182679D3E0BA5A4C9852B1B598D66FCDB819DE397B3A31446A7C77663F64A3 | Rating Details |
| 2023-03-11 07:40:43 -0600 | 347C2B3499FDF9454BA4EBE2998D9C5DEABB8FC8C796136541E1E7F13BD6AA0A | Rating Details |
| 2023-03-11 05:18:45 -0600 | 4408FA4C9188DA49198698D87D78B1C9D372067A4E1AF1939B73B6929B22DF7E | Rating Details |
| 2023-03-10 15:07:31 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
| 2023-03-11 09:01:20 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
| 2023-03-11 08:36:26 -0600 | 46BA3960720D5039DB58AA92963D4FC0D4140DF4432AAF6A16E02DE6C1E740AA | Rating Details |
| 2023-03-11 08:02:47 -0600 | 56948110F9CAF54055BD38677D7945CB43509B9E4794B5B8E35D938B9E38E1D5 | Rating Details |
| 2023-03-11 07:29:35 -0600 | 57CC6C2EB887388232387CB2B620CD2BD14D1DC48E2BE6D224C8872187818C02 | Rating Details |
| 2023-03-11 02:53:04 -0600 | 5B62232E191510C536CFAFAEB5AACF0FAD810E4CD596B1E34F3A2980EB2C47ED | Rating Details |
| 2023-03-10 20:35:20 -0600 | 5B66C2C2840AD455FDAC3D1F25BF92AD35DB04D16E6BE11F99C2E62BAC83F418 | Rating Details |
| 2023-03-11 08:41:46 -0600 | 5F90CE8FAE0A3E7463E992FEB65C1FFE0F44F47B2F72EC8DAB9530168C905099 | Rating Details |
| 2023-03-11 07:51:08 -0600 | 63708118D742687268F91426F6ABEA996B736021FC4955D4D54EF1DFF4165790 | Rating Details |
| 2023-03-11 07:10:15 -0600 | 6DDFD1980C89322930640AE6C1026CB26D4B62EA6ED17FF91676C25A5BE596D6 | Rating Details |
| 2023-03-11 12:36:22 -0600 | 6E0AD26910C4D2F88BF7EE613CEF7E77A93E09FC33B330A017BE413F3CAB8F5D | Rating Details |
| 2023-03-10 14:21:03 -0600 | 6EFCEEF8B2FD28B46A0AC920CAB617AAFD94E40F41CBB21B3427B60CBC26799A | Rating Details |
| 2023-03-11 07:19:11 -0600 | 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061 | Rating Details |
| 2023-03-10 19:08:46 -0600 | 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C | Rating Details |
| 2023-03-10 14:48:29 -0600 | 735CE5611F5264FE2F168B39682A44DCD6EE4049C3EFC07F6A5E8E13C85D4B88 | Rating Details |
| 2023-03-11 09:31:38 -0600 | 7BC4AAD6E2ACA94A0ED25096707AC777815EAD072063C42546F6D031CBAA0BFA | Rating Details |
| 2023-03-11 08:40:06 -0600 | 7C318A55DA967AF307404F852FA3E254598BEE744D950C842E03E0C6CD019D14 | Rating Details |
| 2023-03-11 12:00:09 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
| 2023-03-11 07:48:24 -0600 | 8303B865EC2F829B13C5BC7A3B1CD4F02632ED9A1EDA98121DB182AE4D6527AF | Rating Details |
| 2023-03-10 17:13:44 -0600 | 8397B8EFF5E66D74E3D766849AAD6651C15A83BE48BE57BF0E5A1A8D5A1A4AE7 | Rating Details |
| 2023-03-11 08:44:36 -0600 | 8487591E4463E8B3C6534E72CFE0A65EF3CB7E3D44909BE7BC836654952C5C3B | Rating Details |
| 2023-03-10 21:37:59 -0600 | 861AC5329C7550A5F5EAD859F3BD890F51C233A4DFEA0F2BF530F89F15902B21 | Rating Details |
| 2023-03-11 08:08:17 -0600 | 862E84AD6C488AB3037EAC4682346692F09F61D556BF80E01E4F8B21C28D08CA | Rating Details |
| 2023-03-10 15:53:23 -0600 | 9AD595B701167DE73F25FC67E8E758737FE297EB40C6B14DFA15EAE009148C91 | Rating Details |
| 2023-03-10 13:44:57 -0600 | 9E2542433FE055CBA699C5BEFB0B26A4264D7132E4490E602FBE123D2E5015F2 | Rating Details |
| 2023-03-10 16:07:19 -0600 | A1A3CEBE1775A06C024D0C3849A7A3C1B802A20DC198F0974F4084B92DCDBDE8 | Rating Details |
| 2023-03-11 07:41:05 -0600 | A6A7A86154539ECC873B48E39F40E05439E638A117D91766281E7E168FDD0561 | Rating Details |
| 2023-03-10 14:28:42 -0600 | B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A | Rating Details |
| 2023-03-11 08:01:31 -0600 | B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A | Rating Details |
| 2023-03-11 08:06:10 -0600 | BF7F71DE6A704437DABA39F8712A67759E56706FDCAF390F0D11D6EFB61A769E | Rating Details |
| 2023-03-11 08:13:37 -0600 | C035D750AB8B340BF49F5276E70A2C3A8A302DFF0D6C9DA3A98A5C9AF54F1FBC | Rating Details |
| 2023-03-10 14:14:17 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
| 2023-03-10 14:21:45 -0600 | C437BE8E4062C8CAA7E362249EACB1A6E7F9E9213F151B891AD69EA99A80FC26 | Rating Details |
| 2023-03-11 09:56:01 -0600 | D1AD78A534180E000E161C1FB712DE5182FCFB42BE03F5179E2B0D42533E10BC | Rating Details |
| 2023-03-10 17:16:11 -0600 | D6E96CE95F56B945D9E82BDA403B19C532EC044765F37F4BD6BFB7281DB19034 | Rating Details |
| 2023-03-10 17:56:30 -0600 | DC1B038605EB7B153771BACDFFE6C9D25363704191B3240E4AAC28B7E18C77A6 | Rating Details |
| 2023-03-11 08:06:18 -0600 | DD1D98D11D2CB9A557D210F06D824981A51A01F8E2E0C2A3DCFB37486EDBCD06 | Rating Details |
| 2023-03-11 08:57:24 -0600 | DED02447B6E5427B0E780F7ED69CBB4CBCEA6575BDF3F728311897471FC29442 | Rating Details |
| 2023-03-10 16:13:19 -0600 | E5622AAE1AB71E1FAD3A7F0D3A737EE01EF94423896E0FC3D0ACB9800501C93B | Rating Details |
| 2023-03-10 14:11:27 -0600 | E712DC4736339E9539378C40CB08FA2BC513BB9F2E2799A76AA9B944C5A6D9C3 | Rating Details |
| 2023-03-11 08:24:42 -0600 | E8789B9DB29774C829DBAED31D6E2792A3EF8F9DB34A6FA7F9F49B477D3DE3F2 | Rating Details |
| 2023-03-10 22:15:41 -0600 | EA94FEEE07AEA23F40B647CBA7C22CFB8D0CDF02E6BB10A13314AD0BFEC7806D | Rating Details |
| 2023-03-10 14:27:53 -0600 | F01474B57CB482EF6467795CAFAA5AD30D7BEDC7D62798BB0158B4E9AFD70D18 | Rating Details |
| 2023-03-10 14:02:41 -0600 | FB8F994188E38BFD1DFEFF432935510AB59D03F134241C3190727EA902477234 | Rating Details |
| 2023-03-10 14:13:13 -0600 | Rating Details | |
| 2023-03-10 17:16:11 -0600 | Rating Details | |
| 2023-03-11 07:48:24 -0600 | Rating Details | |
| 2023-03-11 07:29:35 -0600 | Rating Details | |
| 2023-03-11 09:56:01 -0600 | Rating Details | |
| 2023-03-11 09:57:37 -0600 | Rating Details | |
| 2023-03-11 09:01:20 -0600 | Rating Details | |
| 2023-03-11 08:06:10 -0600 | Rating Details | |
| 2023-03-11 02:11:26 -0600 | Rating Details | |
| 2023-03-11 09:31:38 -0600 | Rating Details | |
| 2023-03-10 22:15:41 -0600 | Rating Details | |
| 2023-03-11 12:36:22 -0600 | Rating Details | |
| 2023-03-11 07:41:05 -0600 | Rating Details | |
| 2023-03-10 14:13:13 -0600 | Rating Details | |
| 2023-03-10 13:44:57 -0600 | Rating Details | |
| 2023-03-10 16:13:19 -0600 | Rating Details | |
| 2023-03-11 07:51:08 -0600 | Rating Details | |
| 2023-03-11 08:01:31 -0600 | Rating Details | |
| 2023-03-10 21:37:59 -0600 | Rating Details | |
| 2023-03-10 14:14:17 -0600 | Rating Details | |
| 2023-03-10 14:27:53 -0600 | Rating Details | |
| 2023-03-10 15:07:31 -0600 | Rating Details | |
| 2023-03-11 08:41:46 -0600 | Rating Details | |
| 2023-03-11 08:24:42 -0600 | Rating Details | |
| 2023-03-11 08:02:47 -0600 | Rating Details | |
| 2023-03-10 14:48:29 -0600 | Rating Details | |
| 2023-03-10 17:13:44 -0600 | Rating Details | |
| 2023-03-10 14:28:09 -0600 | Rating Details | |
| 2023-03-11 08:04:02 -0600 | Rating Details | |
| 2023-03-11 08:57:24 -0600 | Rating Details | |
| 2023-03-10 14:02:41 -0600 | Rating Details | |
| 2023-03-11 07:40:43 -0600 | Rating Details | |
| 2023-03-10 14:21:45 -0600 | Rating Details | |
| 2023-03-11 12:00:09 -0600 | Rating Details | |
| 2023-03-11 05:18:45 -0600 | Rating Details | |
| 2023-03-10 20:35:20 -0600 | Rating Details | |
| 2023-03-11 08:44:36 -0600 | Rating Details | |
| 2023-03-10 19:08:46 -0600 | Rating Details | |
| 2023-03-11 08:08:17 -0600 | Rating Details | |
| 2023-03-10 16:07:19 -0600 | Rating Details | |
| 2023-03-10 14:28:42 -0600 | Rating Details | |
| 2023-03-11 08:40:06 -0600 | Rating Details | |
| 2023-03-10 14:21:03 -0600 | Rating Details | |
| 2023-03-10 15:53:23 -0600 | Rating Details | |
| 2023-03-11 02:53:04 -0600 | Rating Details | |
| 2023-03-11 08:06:18 -0600 | Rating Details | |
| 2023-03-11 08:13:37 -0600 | Rating Details | |
| 2023-03-10 14:11:27 -0600 | Rating Details | |
| 2023-03-11 07:27:38 -0600 | Rating Details | |
| 2023-03-10 17:56:30 -0600 | Rating Details | |
| 2023-03-11 07:10:15 -0600 | Rating Details |